News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
Visual Function After Macular Hole Surgery
Source: Medscape Ophthalmology Headlines [2013.06.14]
A study evaluates retinal microstructure and visual function after macular hole surgery using brilliant blue G vs indocyanine green to make the internal limiting membrane more visible.
Medscape Ophthalmology
No Proof Of Added Benefit Found For Aflibercept In Wet Age-Related Macular Degeneration
Source: Eye Health / Blindness News From Medical News Today [2013.06.07]
Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD)...
How Deposits Of Cholesterol Contribute To Macular Degeneration And Atherosclerosis
Source: Cholesterol News From Medical News Today [2013.04.04]
A new study raises the intriguing possibility that drugs prescribed to lower cholesterol may be effective against macular degeneration, a blinding eye disease. Researchers at Washington University School of Medicine in St. Louis have found that age-related macular degeneration, the leading cause of vision loss in Americans over 50, shares a common link with atherosclerosis...
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
Macular Degeneration
Source: MedicineNet Tonometry Specialty [2011.05.20]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 6:05:00 PM
Last Editorial Review: 5/20/2011 12:00:00 AM
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
AREDS2: The Bottom Line on Supplements for AMD
Source: Medscape Ophthalmology Headlines [2013.06.12]
When patients ask about the use of supplements for macular degeneration, what advice should you give, now that the results from the AREDS2 trials are in?
Medscape Ophthalmology
AREDS2: No Cure, but Not a Failure
Source: Medscape Ophthalmology Headlines [2013.06.11]
AREDS2 is an important step in the quest to halt the progression of age-related macular degeneration.
Medscape Optometry
Adding Omega-3 Fatty Acids And Lutein/Zeaxanthin To Formulation Does Not Further Reduce Risk Of Progression To Advanced AMD
Source: Eye Health / Blindness News From Medical News Today [2013.05.08]
In a large, multicenter, randomized clinical trial that included persons at high risk for progression to advanced age-related macular degeneration (AMD), adding the carotenoids lutein and zeaxanthin, the omega-3 fatty acids DHA and EPA, or both to a formulation of antioxidant vitamins and minerals that has shown effectiveness in reducing risk did not further reduce risk of prog...
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.
|
